The efficacy and tolerability issue of generics of imatinib in the treatment of chronic myeloid leukemia: do generics really jeopardize patient safety?

Leuk Lymphoma. 2015 Apr;56(4):1182-3. doi: 10.3109/10428194.2014.947609. Epub 2014 Aug 20.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Female
  • Humans
  • Leukemia, Myeloid, Chronic-Phase / drug therapy*
  • Male

Substances

  • Antineoplastic Agents